full list rate price target
earn chang report pleas see
tabl page
begin deal final puzzl
piec aet
thursday close labcorp ow quest ew deliv earli holiday
weekend treat announc lab establish long-term strateg
partnership believ open contract let
quest back base case outcom investor expect
though confirm remov uncertainti contract begin
januari includ broad rang value-bas program
encourag patient reward high-qual lab test best valu well drive
real-tim data share person care support quest labcorp note
special contract futur chang benefit design highlight
valu proposit nation lab vs industri particip continu
believ also like aetna open network access labcorp start
final piec puzzl watch chanc catch-up
labcorp reiter prior commentari make good
progress aetna addit quest manag note sever time
period exclus long-term aetna contract end end
coincid time new contract would unnecessari
competit disadvantag aetna remain exclus one nation lab
everi nation payor includ labcorp quest in-network provid
given time payor market network design plan year think
possibl announc relat aetna could immin
continu believ would major strateg posit labcorp quest
nation payor open contract nation lab
describ past market like nation exclus relationship
begin almost billion market valu collect destroy
labcorp quest contract initi sign view
normal function duopoli nation lab began compet one
anoth price negoti oligopoli payor fundament
contract open would allow labcorp quest leverag advantag
scale compet directli region independ lab sever time
confer call quest reiter opportun share gain lie
lab industri beyond two nation lab hunt licens
labcorp busi addit focu valu versu price help shine light
substanti valu proposit nation
lab offer versu
competit least difficult us see market would punish
labcorp quest contract enter also way back
contract open believ announc help improv visibl
two nation lab low-cost provid diagnost industri
continu aggreg share time fragment lab industri
action better visibl renew may play expect
rais price target quest labcorp
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
summari rate price target earn chang report chang shown bold
laboratori corp america hldg lh
barclay research share price target price shown primari list currenc ep estim shown report currenc
current fiscal year estim barclay research fiscal year estim barclay research
valuat methodolog risk
laboratori corp america hldg lh
valuat methodolog price target repres ebitda estim billion
risk may imped achiev barclay research valuat price consider uncertainti around
protect access medicar act pama could impact reimburs clinic lab start nearer term expect
reimburs continu remain pressur least inflationari physician consolid could drive lab market share
valuat methodolog price target repres ebitda estim billion
risk may imped achiev barclay research valuat price consider uncertainti around
protect access medicar act pama could impact reimburs clinic lab start nearer term expect
reimburs continu pressur least inflat physician consolid could drive lab market share toward
thursday close labcorp quest deliv earli holiday weekend treat
announc lab establish long-term strateg partnership
believ open contract let quest back
base case outcom investor expect though confirm
remov uncertainti contract begin januari
includ broad rang value-bas program encourag patient reward
high qualiti lab test best valu well drive real-tim data share
person care support quest labcorp note special contract
futur chang benefit design highlight valu proposit nation
lab vs industri particip continu believ also like aetna
open network access labcorp start final piec
puzzl watch chanc catch-up labcorp reiter prior
commentari make good progress aetna addit quest
manag note sever time period exclus long-term aetna
contract end end coincid time new unitedhealth
contract would unnecessari competit disadvantag aetna remain
exclus one nation lab everi nation payor includ labcorp
quest in-network provid given time payor market network design
plan year think possibl announc relat aetna could
continu believ would major strateg posit labcorp quest
nation payor open contract nation lab describ
past market like nation exclus relationship begin almost
billion market valu collect destroy labcorp quest
contract initi sign view normal function
duopoli nation lab began compet one anoth price negoti
oligopoli payor fundament contract open would allow
labcorp quest leverag advantag scale compet directli
region independ lab sever time confer call quest reiter
opportun share gain lie lab industri beyond two
nation lab hunt licens labcorp busi addit focu
valu versu price help shine light substanti valu proposit
nation lab offer versu competit least difficult us see
market would punish labcorp quest contract enter
also way back contract open believ announc help
improv visibl two nation lab low-cost provid diagnost
industri continu aggreg share time fragment lab industri
better visibl renew may play expect rais
price target quest labcorp
updat model either lab time though opportun share gain
consolid test increas convict upsid case stock
quest compani specif note contract sign help
compani abil achiev higher trajectori relat previou commentari
long-term guidanc low end revenu growth mid-to-high
singl digit earn growth contract also help quest achiev revenu
earn growth rais price target repres
ebitda forecast million prior price target repres
ebitda forecast
labcorp compani note pleas outcom renew
given labcorp messag investor contract open
would expect price increas believ like case degre rais
price target repres ebitda forecast
million prior price target repres ebitda forecast
continu see real strateg posit nation lab labcorp quest
exclus contract nation payer aetna respect open
in-network access lab recent announc quest join labcorp
in-network provid good first step wait
updat aetna lab strategi final puzzl piec duopoli negoti
oligopoli nation lab histor lost rate discuss given
threat move out-of-network process cede unit price
time payor extract valu benefit lab scale payor open in-
network statu lab decis would indic commerci insur
custom employ demand broader access network labcorp
quest jointli provid labcorp quest regain foot futur
negoti discuss larg payor
market like nation exclus contract begin
difficult us see nation lab get penal way back well
look back histor stock perform believ market recognit
decis move sole provid relationship larg payor
favor lab term set balanc power almost billion
market valu destroy upon format labcorp/unitedhealth
quest/aetna nation lab deal given quest labcorp trade
upon respect contact loss clear market valu destruct
independ lab aggreg due move sole nation lab model
stock perform around labcorp/unh deal
index
stock perform around quest/aet deal
index
believ decis includ quest back in-network repres
consensu outcom labcorp unitedhealth sole nation lab provid sinc
januari contract extend end point quest join
compani in-network provid taken announc would
like repres headwind labcorp volum opportun share
gain lab make test pie help balanc risk
compani believ lab comment negoti valu
rate goal maintain increas price upon renew support favor
outcom sharehold base announc clear
laboratori go work togeth aggress drive volum toward low
cost provid notabl believ like labcorp regain in-network
statu aetna would larg off-set loss volum
contract open
await announc aetna regard lab strategi believ
commerci insur competit environ make like compani
follow unitedhealth lead lab contract current stand believ
aetna maintain sole nation exclus relationship quest could
potenti put payor disadvantag network breadth perspect rel
peer note labcorp
quest in-network provid believ unlik one payor would want
stand alon weaker lab network breadth rest peer
labcorp revenu mm total
quest revenu aetna mm total
broadli believ evolv manag care contract practic go
creat ration price environ clinic laboratori industri
histor provid healthcar reimburs util basi fee-for-
servic regardless patient outcom rel countri develop world
led high level healthcar spend weaker perform key health
indic goal value-bas care initi incentiv provid
improv qualiti care simultan lower cost healthcar
system isnt one specif mechan drive chang high-qual
low-cost provid laboratori servic hard imagin scenario labcorp
doesnt win environ lay sever principl mechan value-
base care describ labcorp posit context
improv prevent care treatment chronic diseas take
proactiv approach monitor patient health healthcar system reduc
futur spend medic visit costli emerg treatment chronic
 rev total lab aet revsaet total barclay life scienc tool diagnost
diseas believ util laboratori servic would critic aspect
approach
bundl payment cost share arrang
arrang provid reimburs episod care singular payment
provid meant cover entir cost care often includ follow-up
care need scenario provid incent order necessari
lab test lowest cost provid similar medicar reimburs
dynam inpati laboratori test cost share arrang provid
receiv bonu deliv servic lower cost introduc similar
incent select low cost provid
payment align outcom futur value-bas care mechan could focu
align price healthcar product servic valu provid
patient given recent focu drug price believ would like start
point program natur medic access drug develop
servic covanc equip help biopharma compani demonstr valu
drug addit implement diagnost would equal play
field labcorp given compani hospit competitor receiv premium
reimburs similar servic
continu care use data leverag healthcar technolog ehr
patient treat seamlessli across site care improv effici
healthcar system reduc redund cost expertis nation lab
posit well environ greater focu healthcar data share
addit data increasingli use improv patient manag labcorp
natur partner given wealth diagnost data given compani patient reach
labcorp experi million patient encount annual aggreg
databas billion lab test result
person medicin
learn
differ materi impact efficaci differ treatment
learn patient like benefit given treatment elimin
wast healthcar system improv patient outcom diagnost labcorp
exposur trend genom test portfolio addit
combin compani expertis companion diagnost believ labcorp
well-posit support develop target therapeut
refer price exampl mechan could use payor shift
volum toward low cost provid recent studi dr jami robinson uc
berkeley publish journal american medic associ jama intern
medicin show implement refer price polici laboratori
test result reduct price spend employ employe well
consolid toward nation lab dr jami robinson studi compar laboratori
price select employe larg retail claim data
period time refer price mechan use insur compani
cap amount contribut given diagnost test procedur leav
patient respons remaind cost exampl refer price
vitamin test order avoid cost excess normal out-of-pocket cost
deduct co-pay coinsur patient would need choos provid
offer test less patient get test done insur
would pay patient would respons remain
increas patient cost share lab test price transpar refer
price framework clearli incentiv patient choos lower cost provid
patient avoid fee associ refer price
lower price test reduc patient payment toward deduct third year
follow implement refer price averag price paid per lab test
reduc prior refer price averag price per test
reduc year three program addit total
spend laboratori test declin million three year period out-of-
pocket cost patient reduc million employ spend
reduc million total lab test includ studi repres
total laboratori claim retail test overlap
retail claim use assum similar trend among
remain test studi conclud total estim save million
averag price diagnost test follow refer price
journal american medic associ jama barclay research
quest provid detail aetna on-going negoti labcorp
believ manag tone impli labcorp return in-network statu
like background quest aetna sole nation lab provid sinc juli
quest contract aetna renew past period exclus
end end labcorp current engag convers aetna
regard potenti return in-network provid comment past
negoti posit hope back in-network quest
reiter relationship aetna remain strong though
input decis quest make labcorp interestingli manag note
quest target share gain remain billion lab
market control labcorp quest view statement
acknowledg quest opportun acceler growth would larg
impact labcorp return aetna network overal continu believ also
like aetna extend network access labcorp start
labcorpceo dave king value-bas care combin world-class diagnost drug develop capabl critic acceler progress precis person healthcar help choos right test right patient right time offer innov molecular genet test deliv next-gener life-sav drug labcorp critic player enabl target tailor high-valu care qualiti scale expertis standard platform payer provid collabor support goal bring differenti valu value-bas care term value-bas care see shift term payer provid think reimburs think context spend drive decis enhanc valu proposit beyond simpli deliveri lab result precis medicin companion diagnost abil deliv right test right patient right time also deliv thing like chronic kidney diseas solut kidney stone recurr solut actual help provid deliv care accord guidelin valu covanc add valu abl bring health system larg physician group opportun particip trial get acut ill patient access cutting-edg medic whole rang capabl around combin enterpris view posit us better anybodi els deliv value-bas care environ questceo steve rusckowski continu wide variat price commerci side nearest competitor lowest price hospit highest price regard consum get smarter variat price health insur compani get smarter well move away fee-for-servic value-bas deliveri system longer volum cost serv valu bring tabl also relat stakehold chang see big chang dialogu healthcar insur compani relat move fee-for-servic valu see consolid hospit marketplac view futur integr deliveri system final see consum becom increasingli bigger import part busi everi day technolog continu underpin busi strong develop compani genom tremend amount inform inform import busi diagnost inform servic import appli data servic popul health also look way bend cost curv barclay life scienc tool diagnost
laboratori corp america hldg lh
overweight labcorp remark track
record execut led lead organ
growth augment value-enhanc
acquisit covanc acquisit continu
theme expect expertis
organ posit labcorp premier
partner choic companion diagnost play
greater role clinic decis make
labcorp integr strategi covanc yield
higher sustain growth profil compani
addit lab industri consolid lead
acceelr revenu ep growth upsid
case reflect upsid ep
reimburs headwind congression
action oner clinic lab
hospit begin greater penetr esoter test
volum downsid case reflect
downsid ebitda billion
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight thesi quest rel
balanc compani financi flexibl
leverag scale deploy capit peer
said quest may need play catch-up
strateg integr solut across
clinic research clinic test
deploy capit better-than-expect
margin improv would repres upsid
estim upsid case reflect
upsid ebitda billion
reimburs headwind congression
action oner clinic lab hospit
penetr esoter test volum increas
downsid case reflect downsid ebitda
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
meehan cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
